Literature DB >> 27208197

Role of Doppler Sonography in Early Detection of Splenic Steal Syndrome.

Chaolun Li1, Cristiano Quintini2, Koji Hashimoto2, John Fung2, Nancy A Obuchowski1, Mark J Sands1, Weiping Wang3.   

Abstract

OBJECTIVES: To retrospectively investigate the role of Doppler sonography in the early detection of splenic steal syndrome.
METHODS: Fifty cases of splenic steal syndrome after orthotopic liver transplantation were identified. A control group was matched to the splenic steal syndrome group. Information was collected about the clinical presentation, liver enzyme levels, Doppler sonographic results, and follow-up after patients underwent splenic artery embolization.
RESULTS: A persistent hepatic arterial diastolic reversal waveform was observed in 25 patients with splenic steal syndrome versus 0 control patients. The mean hepatic arterial resistive index (RI) values ± SD were 0.95 ± 0.09 in patients with splenic steal syndrome and 0.80 ± 0.10 in control patients (P < .0001). One week after orthotopic liver transplantation, the area under the receiver operating characteristic curve for the RI was 0.884 (95% confidence interval, 0.793-0.975; P = .001) for splenic steal syndrome diagnosis. After splenic artery embolization, there was normalization of the reversal waveform, with an average RI of 0.77 ± 0.11 (P < .0001).
CONCLUSIONS: Dynamic changes in the hepatic arterial waveform and RI are keys to detecting splenic steal syndrome with Doppler sonography.

Entities:  

Keywords:  Doppler sonography; gastrointestinal ultrasound; liver transplantation; sonography; splenic artery

Mesh:

Year:  2016        PMID: 27208197     DOI: 10.7863/ultra.15.06072

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  1 in total

1.  The use of splenic artery embolization to maintain adequate hepatic arterial inflow after hepatic artery thrombosis in a split liver transplant recipient.

Authors:  Kevin Ricci; El-Hinnawi Asharf
Journal:  Int J Surg Case Rep       Date:  2018-09-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.